CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,581 | -40.0% | 1,555 | -25.8% | 0.00% | -25.0% |
Q2 2023 | $117,725 | -2.6% | 2,097 | -21.5% | 0.00% | 0.0% |
Q1 2023 | $120,808 | +37.7% | 2,671 | +23.8% | 0.00% | +33.3% |
Q4 2022 | $87,722 | -44.8% | 2,158 | -11.7% | 0.00% | -50.0% |
Q3 2022 | $159,000 | -12.2% | 2,445 | -18.2% | 0.01% | 0.0% |
Q2 2022 | $181,000 | +144.6% | 2,988 | +203.0% | 0.01% | +200.0% |
Q4 2021 | $74,000 | -16.9% | 986 | +23.9% | 0.00% | -33.3% |
Q3 2021 | $89,000 | -4.3% | 796 | +37.0% | 0.00% | -40.0% |
Q2 2021 | $93,000 | +82.4% | 581 | +37.7% | 0.01% | +66.7% |
Q1 2021 | $51,000 | – | 422 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |